Market Research Blog – Page 9106 – New Product Development

Weight Loss and Obesity Management Market to attain a valuation of US$ 4.99 Billion by 2028 | FMI

The growth of weight loss and obesity management market is attributed to the rising epidemic of obesity across the globe. According to the latest research by Future Market Insights (FMI), the global weight loss and obesity management market is anticipated to reach a valuation of over US$ 4.9 Bn, by the end of 2028. The weight loss and obesity management market is expected to expand at a steady CAGR of 5.2%, over the forecast period of 2018-2028.

Developing Regions More Prone to Obesity & Other Comorbidities

Increasing number of cases of obesity and related comorbidities will lead to the growing adoption of drugs and devices for weight loss and obesity management, which will further fuel the growth of the global weight loss and obesity management market during the forecast period.

The weight loss and obesity management market is majorly driven by the rising prevalence of obesity. The rising epidemic of obesity presents a major challenge to disease prevention across the globe. It is estimated that by 2030, 38% of the world’s adult population will be overweight and around 20% will be obese. This obesity epidemic is more prevalent in the Middle East and the Asia Pacific regions where food import is quite high. Weight loss and obesity management are helpful in the treatment of highly critical obesity and comorbidities associated with it, such as diabetes, asthma, sleep apnea, and hypertension, etc.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-411

Increasing health consciousness is also cited as an important factor boosting the revenue growth of the global weight loss and obesity management market. Sizeable consumer population in developed regional markets will particularly continue to generate high demand for weight loss and obesity management practices, according to the report. Millennial and Generation-X consumers are gradually adopting advanced aesthetic services, including weight loss and obesity management, thereby creating adequate opportunities for manufacturers of weight loss and obesity management drugs and devices.

Key Players:

Novo Nordisk A/S,
GlaxoSmithKline plc.,
F. Hoffmann-La Roche AG,
Allergan Plc,
Johnson & Johnson Services, Inc,
Medtronic plc.,
Vivus Inc.,
Eisai Co., Ltd.,
ReShape Lifesciences, Inc,
Obalon Therapeutics,
Aspire Bariatrics,
Allurion Technologies Inc.,
Nalpropion Pharmaceuticals, Inc., and
Beijing Noble Laser Technology Co., Ltd.

Key Vendors Targeting Extension of Product Portfolio

Leading companies operating in weight loss and obesity management market are majorly focusing on strengthening their product portfolio. Product line extensions help companies to launch newer products with unique features for specific indications. This results in an increased market share of companies in the highly competitive weight loss and obesity management market. In response to increasing demand from various healthcare professionals to effectively treat obesity with minimum long-term side effects, manufacturers are focusing on developing innovative and specific products.

Product innovation is expected to boost revenue and volume growth of the weight loss and obesity management market during the forecast period. For instance, an additional FDA patents approval for VIVUS, Inc.’s Qsymia, for the covering compositions of Qsymia and covering methods for effecting weight loss using Qsymia (phentermine and topiramate).

However, the high cost involved in research and development of obesity drugs is a great challenge for the growth of the weight loss and obesity management market. Additionally, long gestation time required for research and developmental activities as well as the need for a number of essential clinical trials to test drugs adds up to significant expenditure. The limitations posed by high development cost of anti-obesity drugs might hinder the growth of the global weight loss and obesity management market. Moreover, the high cost of surgical procedures, such as gastric bypass surgery, adjustable gastric banding, gastric sleeve surgery and gastric balloon treatment, may also affect the growth of the global weight loss and obesity management market adversely.

The global weight loss and obesity management market is estimated based on product type, and distribution sales. Based on product type, the weight loss and obesity management market has been segmented into drugs and devices.

Drugs product type segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, a combination drug, and others. Devices product type segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems.

Devices segment is expected to hold maximum market share in the global weight loss and obesity management market. Based on distribution sales, the weight loss and obesity management market has been segmented into institutional sales and retail sales. In terms of revenue, institutional sales dominated the global weight loss and obesity management market in 2017.

Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-411

Additional Questions Answered

Some of the additional questions addressed in this report on the weight loss and obesity management market-

What is the revenue potential of the weight loss and obesity management market across the regions of emerging economies?
Who are the key competitors in the weight loss and obesity management market and what are their portfolios?
What are the major challenges influencing the growth of the weight loss and obesity management market?

Segmentation

On the basis of product type

drugs
devices

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-411

On the basis of distribution sales

institutional sales
retail sales

On the basis of geographical

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)
emerging countries like China, Brazil, and India.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Generic Oncology Drugs Market is poised to surpass a striking CAGR of 6% through 2028

Increasing incidences of cancer have been detected, ascending from the proclivity for cigarettes and tobacco among individuals. The number of cancer-infected patients is stimulated by viral infections, carcinogens, lack of physical activities, genetic causes, age, and unhealthy eating habits. Recent developments in the healthcare sector have broadened the scope of therapies for the treatment of cancer by leveraging oncology.

Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of growth for the generic oncology drugs market and the cost pertaining to the treatment of cancer. Advanced technologies such as real world data, mobile apps, and artificial intelligence have successfully been able to achieve a high engagement rate of the patients, which has resulted in increasing awareness of the cancer treatment among the patients.

A significant increase has been noted in the spending capacity for the development of cancer. More than one-third of the trials proposed by the manufacturers are aimed at offering personalized cancer treatments, which further propels the demand for generic oncology drugs. A host of these factors have contributed massively to the expansion of the generic oncology drugs market at the global level.

Request Sample @ https://www.futuremarketinsights.com/ask-question/rep-gb-8961

According to a report, the global generic oncology drugs market is poised to surpass a striking CAGR of 6% through 2028. Increasing inclination of individuals towards smoking and tobacco consumption is the chief cause of cancer. Secondary factors such as sedentary lifestyle, genetic causes, viral infections, carcinogens, and high consumption of junk food make the human body susceptible to cancer. Growing concerns of a high number of deaths occurring on the back of cancer have provoked the government authorities to take effective steps for preventing cancer.

Notable Developments in the Generic Oncology Drugs Market

Improvement in cancer treatment drugs and therapies have been one of the most underlying aims of the pharmaceuticals and medical organizations operating at the global level. Consequently, generic oncology drugs have been utilized for innovating novel therapies and increasing the survival rates of patients.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8961

Blood Cancer Immensely Contributes to the Growth of the Generic Oncology Drugs Market

Amongst the various types of cancer such as skin cancer, bladder cancer, bone cancer, eye cancer, gastrointestinal cancer, gynecological cancer, lung cancer, endocrine cancer, and blood cancer is accounted for generating the largest share for the generic oncology drugs market. Patients diagnosed with blood cancer seek complete treatment to this chronic disease, as a result of which excessive demand for generic oncology drugs is created. In addition to this, the high cost of the therapies and generic oncology drugs play a crucial role in the growing size of the generic oncology drugs market.

Recent Developments to Drive the Growth of the Generic Oncology Drugs Market

The key players involved in transforming the landscape of the generic oncology drugs market include

Bayer Healthcare AG
Amgen
Teva Pharmaceutical Industries
Pfizer
Boehringer Ingelheim GmbH
AstraZeneca
Hoffmann-La Roche Ltd.
Eli Lily and Company
ARIAD Pharmaceuticals Inc.
GlaxoSmithKline
CELGENE Corporation
Novartis AG
Johnson and Johnson
AbbVie Inc.
Merck & Co.
Sanofi

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8961

Out of these leading players, CELGENE, Novartis, and Roche have been procuring a considerable share in the generic oncology drugs market with a rich product portfolio and pipeline products aimed at treating cancer effectively.

Novartis AG applied smart strategies for channel integration like eCommerce with mobile application to fuel the sales at the retail stores. In addition to this, the company achieved a CE mark for its gene modifying therapy used for the treatment of blood cancer.

Pfizer Inc. has been focusing on the over 39 therapies, in order to fortify its product portfolio. In the year 2017, Glasdegib of Pfizer received the priority review from the U.S. FDA to treat myeloid leukemia. Post this, XTANDI of Pfizer as well received the FDA approval.

Many similar key development shaping the landscape of the existing generic oncology drugs market have been incorporated in the report.

About FMI:

Immunoassay Market is projected to be worth USD 45.78 billion by 2032 | FMI

The i mmunoassay market is expected to observe growth at a CAGR of 5% and is anticipated to touch a valuation of USD 45.78 bn by 2032, while it holds a revenue of USD 29.51 Bn in 2022

The dynamic shift from the last forecast period (2017-2021) to the current forecast period (2022-2032) is significant. The major factors that have shaped the growth dynamics are the advent of covid-19, the geriatric population, and rising awareness around health

With the environment changing and climate change-based diseases and viruses growing in the urban and rural areas, the demand for vaccines is on a rise. The immunoassay market survey explains that the tests of the effectiveness of these vaccines are conducted through immunoassays tests that include the strength of antibodies in the immune system, fueling the sales of immunoassay testing kits.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15437

Rising awareness, government research and development programs, and covid-19’s spread has collectively flourished the demand for the antibodies testing systems. Hence, it has expanded the immunoassay market share in the global market

This fueled the market’s growth prospects and brought opportunities for the new medical and healthcare market players to come up with the latest technology and integrate it with immunoassay technology. Furthermore, the breakdown of the third covid-19 wave has partially slowed down the growth of the market as the spread is at lower levels

Key Takeaways from Market Study

The Immunoassay market is expected to increase with a market share of 35.0% in North America.
Asia Pacific is expected to account for 30% market share during the assessment year.
By product, reagents and kits accounted for 60% share of total revenue generated of the immunoassay market globally and is anticipated to hold the highest share by 2032, owing to the cost-effective products, fueling the overall sales of immunoassay testing instrument
EIA/ELISA technology gains the highest traction in the market by technology with a market share of 60% and its growth owing to higher use of it in reducing the assay time for immunoelectrophoretic and immunodiffusion while providing accurate and quantitive results.

Visit for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15437

“Immunoassay market analysis displays the higher growth prospects due to the higher awareness of the new viruses and diseases that demand for higher antibodies in the body. An immunoassay test gives you information about the antibodies present in the body for any specific virus or disease spread by it. Demand for immunoassay tests rises as the hospitals, clinics, and research and development centers established by the government are consuming the most from the market” says a Future Market Insights analyst.

Competitive Landscape

New market research report on immunoassay defines the market space as a younger space where there is a space for innovation and technology. The defining factors key players have been the ability to deliver effective and accurate results while making the product more logistics friendly and easy to use.

Siemens Healthineers has introduced its latest and revised fully automated immunoassay platforms and a comprehensive and disease-specific chart in excess of 100 tests. This enhanced productivity and efficiency while delivering accurate and faster results.
Biomerieux, with more than 26000 immunoassay systems globally has introduced its R7D programs that covers high medical value applications, increased automation and decentralized testing, flourishing the sales of immunoassay platforms.
Abbott Laboratories focuses on chia technology and offers an automatic immunoassay analyzer named Abbott prism, delivers effectiveness and enhances productivity.

Explore More Valuable Insights

Future Market Insights, in its new report, offers an impartial analysis of the global Immunoassay market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.

The study offers compelling insights based on Application (Food, Beverage, Pharmaceuticals, Other (Applications), Form (Natural Immunoassay, Synthetic Immunoassay), Region (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA)

Further Assistance in Purchasing this Report @ https://www.futuremarketi nsights.com/checkout/15437

Immunoassay Market by Category

By Product, Immunoassay Market is segmented as:

Reagents & Kits
Analyzers/Instruments
- Open-ended Systems
- Closed-ended Systems
Software & Services

By Technology, Immunoassay Market is segmented as:

Radioimmunoassay (RIA)
Enzyme Immunoassays (EIA)Rapid Test
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
Others

By End-use, Immunoassay Market is segmented as:

Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Testing
Autoimmune Diseases

By Application, Immunoassay Market is segmented as:

Hospitals
Blood Banks
Clinical Laboratories
Pharmaceutical and Biotech Companies
Academic Research Centers
Others

By Form, Immunoassay Market is segmented as:

Natural Immunoassay
Synthetic Immunoassay

More Trending Reports by Future Market Research :

Humanized Mouse Model Market Trends : The global humanized mouse model market is expected to be valued at US$ 92.5 Million in 2022. Throughout the decade spanning 2022-2032

Medical Cleaning Devices Market Growth : The global Medical cleaning devices market is expected to reach a market valuation of US$ 21.5 Billion by the year 2022.

Breast Cancer Drug Market Analysis : The global breast cancer drug market size is expected to be valued at US$ 10,637.42 Million in 2022.

About FMI:

NGS Sample Preparation Market to be US$ 5.4 Billion by 2032 | Future Market Insights

[342 Pages Report] The global NGS sample preparation market is expected to be valued at $5441.1 million by 2032, up from $1321.8 million in 2022, and to grow at a 13.7% CAGR during the forecast period (2022-2032).

DNA contains the blueprints of life. Within its structures are the codes required for the assembly of proteins and non-coding RNA – these molecular machineries affect all the biological systems that create and maintain life. By understanding the sequence of DNA, researchers have been able to elucidate the structure and function of proteins as well as RNA and have gained an understanding of the underlying causes of disease. Next Generation Sequencing (NGS) is a powerful platform that has enabled the sequencing of thousands to millions of DNA molecules simultaneously.

This technology involves steps such as library preparation followed by clone amplification and cyclic array sequencing. This technology is used for applications including human whole genome sequencing (WGS), whole exome sequencing, targeted sequencing using panels of a few to thousands of genes, and expression profiling.

Get Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4047

NGS Sample Preparation Market: Drivers and Restraints

NSG samples are being used for the sequencing of genomes. These genomes are being used for the preparation of specialized medicines. Increasing prevalence of genetic disorders is driving the growth of this market. Increasing need for the personalized medicines and clinical diagnosis is driving the growth of NGS sample preparation market. Technological advancements in sample preparation procedures and kits to standardize and simplify steps are driving the growth of NGS sample preparation market.NGS Sample Preparation Market: OverviewNGS has revolutionized the genome sequencing market. NGS sample preparation market is expected to show significant growth over forecast period. Increasing need for personalized treatment is driving the growth of this market. Increase in the healthcare spending and improvement in the healthcare technology are the major factors for the growth of NGS sample preparation market. Increasing incidence of disease conditions like cancer and use of NGS for diagnostic purpose in cancer and management or treatment of disease the boosting the growth. Aging population is also expected to drive the growth of NGS sample preparation market. Single molecule real time sequencing is expected to be fastest growing segment due to real time preparation of samples. Drug discovery and diagnostic application are expected be highest revenue generating and fastest growing NGS sample preparation segments. Biopharmaceutical companies are biggest user of NGS samples as these companies are focusing on development of new drugs.

NGS Sample Preparation Market: Region Wise Outlook

Geographically, the NGS sample preparation market can be segmented as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa. North America is most attractive region for the NGS sample preparation market attributing to the presence of key biopharmaceutical players in this region and technological advancements. Followed by which is Europe and Japan. These markets are also growing significantly due to the focus of research institutes on development of new methods of NGS sample preparation and aging population. Asia Pacific excluding Japan is also expected to show significant growth in NGS sample preparation market due to improving healthcare infrastructure and increasing healthcare expenditure.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4047

NGS Sample Preparation Market: Key Players

Some of the market participants in the global NGS sample preparation market are Thermo Fisher Scientific, Agilent Technologies, Inc., F Hoffman-La Roche AG, Illumina, Inc., Eurofins Scientific and Macrogen, Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and grades.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Historical Actual Market Size, 2012 – 2016
Market Size & Forecast 2017 to 2027
Supply & Demand Value Chain
Market Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis for Market includes

North America
Latin America
Europe
Asia Pacific & Japan
The Middle East and Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-4047

NGS Sample Preparation Market: Segmentation

The global NGS sample preparation market can be segmented on the basis of technology, application, end user and region.

On the basis of technology the global NGS sample preparation market can segmented as:

Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single Molecule Real Time (SMRT) Sequencing
Nanopore Sequencing

On the basis of application the global NGS sample preparation market can be segmented into:

Diagnostics
Drug Discovery
Biomarker Discovery
Precision Medicine
Agriculture and Animal Research
Other Applications

On the basis of end user the global NGS sample preparation market can be segmented into:

Biopharmaceutical Companies
Hospitals
Research Institutes
CMOs
CROs

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

More Trending Reports by Future Market Research :

Liquid Biopsy Market Forecast : Global liquid biopsy market demand is anticipated to be valued at US$ 1,146 Million in 2022, forecast a CAGR of 13.49% to be valued at US$ 4,126 Million from 2022 to 2032.

Digital Patient Monitoring Systems Market Value : The global Digital Patient Monitoring Systems market is estimated at US$ 96.4 Bn in 2022 and is projected to reach a valuation of US$ 470 Bn by 2032, expanding at a CAGR of 17.2% through the forecast period of 2022-2032.

Medical Drones Market Sales : The medical drones market is anticipated to flourish in the worldwide market at a strong CAGR of 24.3% during the forecast period, reaching a revenue of US$ 280.6 Mn in 2022

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Automotive Proportioning Valves Market Size Value to Reach US$ 285.4 Million by 2032

As per the report published by FMI, the global automotive proportioning valves market size is projected to have a rapid-paced CAGR of 11.8% during the forecast period. The current valuation of the market is US$ 195.1 Million in 2022. The market value of automotive proportioning valves is anticipated to reach a high of US$ 285.4 Million by the year 2032.

Automotive proportioning valves are gaining traction as they are being widely used in the vehicle’s brake systems for lowering the brake fluid applied to the axle set of the brake systems.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9740

According to the findings of Future Market Insights, an unprecedented surge for the product is underpinned by the rising demand for high-speed racing cars and stringent regulations to mandate the fitment of proportioning valves in passenger and commercial vehicles.

The demand for automotive proportioning valves is also anticipated to gain momentum owing to the need for maintaining a stable balance during emergency braking situations. They are likely to balance the brakes of the vehicles, simultaneously regulating the master cylinder’s fluid flow, and allowing the rear brakes to engage immediately before the front disc.

It is anticipated by the expert analysts at FMI that many unfavorable aspects are hampering the growth of the global automotive proportioning valves. Higher competitive costs, strict pollution regulations, and the use of electric vehicles are likely to stifle the market growth for automotive proportioning valves.

FMI has analyzed that certain technological advancements like the emergence of modern braking systems, and the demand for solenoid valves, with increasing passenger car manufacturing are inevitable to break through and open up new prospects for the market participants. Furthermore, the market is predicted to witness positive growth due to the expansion of the automotive industry and growing sales of LCVs and SUVs.

Key Takeaways from the Automotive Proportioning Valves Market

During the forecast period, the automotive proportioning valves market will expand at a CAGR of 11.8% (2022-2032).
By material type, Steel is estimated to account for the highest share of more than 33% under the material segment in terms of value in 2022.
The LCV segment on the basis of vehicle type, is likely to dominate the market creating an incremental opportunity of nearly US$ 1,603.9 Mn from 2022 to 2032.
The OEM segment by sales channel is set to account for more than 90.2% of the global automotive proportioning valves market.

“Key companies are deploying safe and advanced technology for increased safety regulations for passengers and drivers. Key market players are capitalizing on surging sales of LCVs and SUVs in emerging nations to increase their revenue.” – Says an FMI Analyst

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-9740

Competition Landscape in the Automotive Proportioning Valves Market

Demand for more innovative designs and an increasing focus on manufacturing low-cost machinery and equipment are projected to continue to provide profitable business prospects for big players and new entrants in the industry.

Leading players in the global market are increasingly focusing on investing huge sums in research and development activities to introduce state-of-the-art products. They are also engaging in partnerships and collaborations with domestic players to co-develop new automotive components to cater to the ever-increasing demand from customers.

General Motors, ACDelco, Knorr-Bremse AG, Emmerson Electric Co., Wilwood Engineering, Inc., Heidts Automotive LLC, Veoneer-Nissin Inc, IBARA SEIKI CO., LTD., Baer Brakes, and Baer Inc. are some of the key players in the market.

Key Segments Profiled in the Automotive Proportioning Valves Market Industry Survey

By Product Type:

Master Cylinder-Mounted Automotive Proportioning Valves
Load Sensing Automotive Proportioning Valves
Combination Valve-Mounted Automotive Proportioning Valves

By Vehicle Type:

Conventional Vehicles
Passenger Car
Compact Cars
Mid-size Cars
SUVs
Luxury Vehicles
Light Commercial Vehicles
Heavy Commercial Vehicles
Electric Vehicles

By Sales Channel:

Original Equipment Manufacturer (OEM)
Aftermarket

By Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East and Africa

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-9740

Recent Developments in the Automotive Proportioning Valves Market:

In March 2021, Bendix Commercial Vehicle Systems, LLC notified the National Highway Traffic Safety Administration (NHTSA) that the company will recall 2,090 Bendix SC-3 check valves which are part of an air-brake system, mainly due to manufacturing problems.
In 2020, Danfoss bought Eaton’s hydraulics business to focus on its core business, which includes valves and similar other products.
In April 2020, Veoneer announced an initial agreement to transfer its braking control business in the United States to ZF Friedrichshafen AG for global market development.

About Future Market Insights (FMI)

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Orthopedic Braces and Support Market growth projection to 6.9% CAGR through 2024

Future Market Insights (FMI), in its latest report, has revised the global orthopedic braces market growth projection to 6.9% CAGR through 2024. This revised projection considers the sluggishness induced due to the COVID-19 pandemic.

Advancements in orthopedic braces and support market have offered umpteen benefits, bringing substantial improvements in average quality of life and lifespans.

Tech-driven innovation holds true potential for market players to enhance the understanding of patients, thus enabling at-scale convenience and individualized care.

The healthcare industry is embracing technological intervention with digital health, virtual health, and telehealth to treat patients.

Such trends are emerging as a potential disruptor in the orthopedic braces and support market, which has been facing the brunt of the COVID-19 pandemic.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12207
Key Takeaways of Orthopedic Braces and Support Market Study

The orthopedic braces and support market to grow at robust 6.1% CAGR through 2030
Lower extremity products to capture around 70% revenue share; knee braces and supports to lead the way
East and South Asia to represent potential growth avenues for market players

“Recent tech-driven innovations such as human torso simulator is opening door back brace innovations. The simulator allows development of new back braces that are optimized to restrict specific motions yet allowing for other movements. Moreover, it can assist with design of braces and supports with targeted constraint of movement,” says the analyst at FMI.

COVID-19 Impact on Orthopedic Braces and Support Market

The COVID-19 pandemic has affected every facet of the healthcare industry including, orthopedic braces and supports.

Regular orthopaedic practice has been considerably impacted by the pandemic.

Surgery schedules have been revamped, with elective cases being instantly delayed or cancelled and urgent cases demanding huge attention, particularly in suspected or confirmed COVID-19 cases.

This is having a measurable impact on inpatient management, accenting the need for dedicated personnel, patient quarantine and limited visiting hour regulation.

On the flip side, outpatient visits have been restricted to avoid contacts between patients and the hospital staff, with notable implications on post-operative quality of care delivery and healthcare professionals.

The pandemic has rapidly spurred the adoption of telehealth options such as performing non-urgent check-ups and post-operative visits via electronic mediums instead of in-person.

Visits are being organized by video or by phone. This sudden adoption of telemedicine has triggered a process that would have, otherwise, taken far longer to execute on such a global level.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12207

Orthopedic Braces and Support Market – Competitive Intelligence

The global orthopedic braces and support market is slightly fragmented with presence of limited number of prominent players and large number of small- and medium-scale players. In order to sustain their customer base, market players are investing in product launches.

Otto Bock Healthcare has rolled out Agilium® Vantage, a low-key, wraparound knee brace, that is developed for delivering prolonged pain relief for patients having mild unicompartmental osteoarthritis (OA)
Breg Inc. has developed Breg Quantum™ OA for mild to severe OA in a bid to satiate the need for pain management in arthritic patients

In addition to this, market players are also cashing in on acquisitions in a bid to expand their regional foothold. For instance, 3M has taken on Acelity Inc. and its KCI subsidiaries across the world to expand its offerings in advanced wound care.

Want more insights?

FMI, in its new market research study, offers an unbiased assessment of the orthopaedic braces and support market which comprises global industry analysis for 2015–2019 and opportunity assessment for the 2020–2030. The report delivers complete analysis on orthopaedic braces and support market through three different categories – by product, by distribution channel, and region.

The global orthopaedic braces and support market study provides insights of pricing by different life cycle analysis, product life cycle, key market trends and technologies that are being implemented in the development of orthopaedic braces and supports and product adoption in various end-use industries

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/12207

Orthopedic Braces and Support Industry Research Analysis

Orthopedic Braces and Support Market by Product:

Upper Extremity Braces and Supports
- Shoulder Braces and Supports
- Neck Braces and Supports
- Elbow Braces and Supports
- Wrist Braces and Supports
- Spinal Braces and Supports
Lower Extremity Braces and Supports
- Knee Braces and Supports
- Ankle Braces and Supports
- Hip Braces and Supports

Orthopedic Braces and Support Market by Distribution Channel:

Institutional Sales
- Hospitals
- Orthopedic Clinics
- Nursing Facilities
Retail Sales
- Online Sales
- Retail Pharmacies
- Drug Stores

Orthopedic Braces and Support Market by Region:

North America Orthopedic Braces and Support Market
Latin America Orthopedic Braces and Support Market
Europe Orthopedic Braces and Support Market
East Asia Orthopedic Braces and Support Market
South Asia & Pacific Orthopedic Braces and Support Market
Middle East & Africa (MEA) Orthopedic Braces and Support Market

About FMI:

Digital Health Market is projected to be worth USD 224.24 billion in 2022 | FMI

[306 Pages Report] Digital health has become a buzz word with increasing deployment of digital health platforms such as telehealth, mobile health and other wireless solutions across hospitals and nursing homes so as to provide patients with real time healthcare services.

Impact of digital technology among end-user verticals such as public, retail, banking, financial service and insurance (BFSI) and Manufacturing sectors is phenomenal, but it is becoming a game changer technology in healthcare sector with increasing dependency of end-user on digital health platform. These platforms are being increasingly implemented to perform remote monitoring for chronic disease and to access electronic medical and personal health record through broadband and mobile. Increasing demand for m-health (mobile health) with innovative mobile applications and solutions is expected to catalyze the growth of digital health market across globe.

Digital Health Market Segmentation

On the basis of platform, the global digital health market can be segmented as m-Health, telehealth, wireless health, electronic media record and other. Among all the aforementioned platforms wireless health platform segment is dominating the market at present and is expected to remain dominant during the forecast period from 2015 to 2020. Moreover, electronic medical record segment is projected to occupy the second largest share.

Get Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-505

However, the m-Health segment is likely to exhibit the fastest CAGR over the forecast period. The global digital health market can be segmented based on application, which includes healthcare amenities, e-prescription, home care and remote monitoring & consultancy application. The global digital health market is further segmented based on end-user including hospital & nursing home, physician, healthcare worker and individual. Of all the end-user segments, hospital & nursing home is anticipated to be the largest end-user segment over the forecast period.

Digital Health Market: Region-wise Outlook

The globaldigital health market is expected to witness a healthy CAGR through 2025 due to growing awareness concerning health across the globe. Regionally, the digital health market can be segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan and Middle East & Africa (MEA). Globally, among all the regions, North America is expected to account for the highest share followed by Western Europe over the projected period. US is expected to be the dominant market for digital health in the North America region.

Digital Health Market: Drivers

Rising awareness concerning health, supplemented by growing adoption of smart-phone and tablet are expected to drive the digital health market growth between 2015 and 2020. Moreover, growing penetration of 3G and 4G network and increasing application area is supporting the growth of global digital health market growth. However, stringent regulatory norms in the United States and threat associated with data privacy and security are restricting the growth of global digital health market.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/505

Digital Health Market: Key Players

The key players operating in the global digital health market includes AT&T Inc., Apple Inc., AirStrip Technologies LP, Alcatel-Lucent Corporation, Cerner Corporation, Symantec Corporation, Aruba Networks, Inc., Cisco Systems, Inc., Qualcomm, Inc., Siemens Healthcare and Philips Healthcare. Major players in the market follow the strategy of introducing innovative and cost effective solution to buy out competition. In addition, strategic partnership, collaborations and joint ventures are the other major strategies followed by the digital health solution provider to outperform competitors.

About FMI:

Dyslexia Treatments Market worth US$ 8061.5 Million in 2032 | FMI

Dyslexia is neurologically based and often hereditary. It is associated with difficulties in reading, writing, spelling and organization. Functional Magnetic Resonance Imaging shows that the brains of people with dyslexia develop and function in a different way.3 Dyslexia makes fluent reading difficult, which affects not only academic success but also self-esteem and social-emotional development.

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Dyslexia Treatments Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.

The team of analysts at Future Market Insights are focussing on research and market study to produce different Dyslexia Treatments Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Dyslexia Treatments Market.

To remain ‘ahead’ of your competitors, Ask a Question >> https://www.futuremarketinsights.com/ask-question/rep-gb-5281

Key Players

The writer will create content on the general strategies of market players. And then will write the key players in the market are: DK Pharmachem, Pfizer Inc., RPG Life Sciences Ltd, Wallace Pharmaceuticals Ltd., Cian Healthcare Pvt Ltd, Rhodes Pharmaceuticals, L.P., Purdue Pharma, Apotex Corporation and Unither Pharmaceuticals

Segmentation

The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:

On the basis of drug type the dyslexia treatments market can be segment as:

Cyclizine
Meclizine
Dimenhydrinate
Methylphenidate

On the basis of distribution channel the dyslexia treatments market can be segment as:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Product Segmentation

The investigation offers a top to bottom evaluation of different clients’ journeys pertinent to the market and its segments. The study endeavours to assess the current and future development possibilities, undiscovered roads, factors that shapes their income potential in the global market by breaking it into di such as its types, applications, and region-wise assessment.

Get Access to Research Methodology Prepared by Experts >> https://www.futuremarketinsights.com/askus/rep-gb-5281

By Regional Analysis Covered

North America (U.S., Canada)
Latin America (Brazil, Mexico, Rest Of Latin America)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC countries, S. Africa, N. Africa, Rest Of MEA)

Full in-depth analysis of the parent market

The analysts at FMI are dedicated to provide insights after extensive research and study. The study also includes estimations, projections and evaluation of the market dynamics.

Important changes in market dynamics

The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.

Segmentation details of the market

Former, on-going, and projected market analysis in terms of volume and value
Assessment of niche industry developments
Market share analysis
Key strategies of major players
Emerging segments and regional markets

Queries Solved

What is the size of the overall Dyslexia Treatments Market in the Healthcare Industry and its segments?
What are the key segments and sub-segments in the market?
What are the key drivers, restraints, opportunities, and challenges of the Dyslexia Treatments Market in the Healthcare Industry, and how they are expected to impact the market?
What are the attractive investment opportunities within the Dyslexia Treatments Market in the Healthcare Industry?
What is the Dyslexia Treatments Market in the Healthcare Industry size at the regional and country-level?
What are the key market players focusing on?
What are the strategies for growth adopted by the key players in Dyslexia Treatments Market in the Healthcare Industry?
What are the recent trends in Dyslexia Treatments Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)?
What are the challenges to the Dyslexia Treatments Market in the growth of the Healthcare Industry?
What are the key market trends impacting the growth of the Dyslexia Treatments Market in the Healthcare Industry?

To receive extensive list of important regions, ask for TOC here >> https://www.futuremarketinsights.com/toc/rep-gb-5281

Table of Content

Executive Summary
Market Overview
Key Success Factors
Global Dyslexia Treatments Market – Pricing Analysis
Market Background

Reasons to Buy the report

We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

About FMI:

Skid Steer Loader Market Size worth US$ 2.95 Billion by 2032 | FMI

As per the report published by FMI, the global skid steer loader market size is projected to have a sluggish-paced CAGR of 2.3% during the forecast period. The current valuation of the market is US$ 2.35 Billion in 2022. The market value of skid steer loader is anticipated to reach a high of US$ 2.95 Billion by the year 2032.

Skid steer loaders are gaining traction and the sales can be attributed to the rising demand for energy-efficient construction equipment. The construction industry is anticipated to be the largest end-user of these machines.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10115

According to the findings of Future Market Insights, an unprecedented surge in the demand for skid steer loaders is witnessed due to their ability to work in tight spaces coupled with lowering operational costs, making them the most suitable and preferred option at mining and construction sites.

The demand for skid steer loaders is also anticipated to gain momentum owing to their properties like compact size, the versatility of operations, and ease of maneuver in operations that cannot be met by large vehicles. The fact that these loaders can be outfitted with different attachments like hydraulic hammers, forks, augers, stump grinders, and more, further stimulates the demand for this product.

Since they have the ability to perform multiple tasks the change of attachments is likely to have a positive impact on their adoption across the different industry verticals. However, it is anticipated by the expert analysts at FMI that the skid steer loaders are comparatively costlier and thus, the builders find it difficult to purchase or even rent them on large scale. High prices are preventing the adoption of this equipment in various sectors affecting the overall growth of the skid steer loader market.

FMI has analyzed that the technological advancements in regards to engines used, operator comfort, telematics integration, and rising awareness about the end number of applications are likely to bolster the expansion of the skid steer loader market during the forecast period.

Key Takeaways from the Skid Steer Loader Market

The Construction and Mining segment is expected to witness relatively stronger growth, expanding at a CAGR exceeding 3% during the period 2022-2032.
The 1,251 lbs to 2,200 lbs segment dominated the market for skid steer loaders during the base year, accounting for more than 45% of the volume share.
Asia Pacific/APAC region is expected to expand at a CAGR of over 4% during the estimated period of study by FMI.
North America dominated the global market share for skid steer loaders in 2021 with a revenue share of more than 75%.
North America is projected to expand at a CAGR of 2% during the forecast period.

“With the expansion of the global construction industry, coupled with the rising trend of rental systems flourishing, many new building projects are getting introduced across the countries. This is likely to impact the sales of skid steer loaders during the period 2022-2032” – Says an FMI Analyst

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10115

Competition Landscape in the Skid Steer Loader Market

The forum is identified to be moderately consolidated, and the biggies are making efforts to sustain their market position.

The market payers from the skid steer loader market are anticipated to have lucrative growth opportunities in the future with the rising demand and application of skid steer loaders globally. They are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations

Market players are also launching new products, and service lines, and ensuring competitive prices for acquiring larger shares.

Bobcat Company, CNH Agriculture N.V., ASV Sales & Services, Komatsu Ltd., and Wacker Neuson SE are some of the key players in the market.

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-10115

Recent Developments in the Skid Steer Loader Market:

In September 2019, Yanmar Holdings announced the acquisition of ASV Holdings. ASV Holdings is one of the leading suppliers of skid steer loaders and compact tracked loaders. The acquisition helped Yanmar Holdings to leverage the strong dealer network of ASV Holdings and consolidate its position worldwide, especially in North America.
In October 2018, Bobcat announced the new S100E skid steer loader with a stage V emission standard compatible engine. The machine included a rear camera, auto ride control, cushioned cylinders, LED sidelights, heated cloth air seat, and an auto-reversing fan among other prominent features.

About Future Market Insights (FMI)

Contact:

Implantable Collamer Lens Market is estimated to reach a valuation of US$ 244.8 Mn in 2022

[250 Pages Report] As per Future Market Insights’ latest industry analysis, the valuation for the global implantable collamer lens market was around US$ 212.9 Mn in 2021. Sales are projected to grow at a 13.1% CAGR over the forecast period, with the market valuation reaching US$ 838.2 Mn in 2032.

Since phakic intraocular implants were approved two decades ago, refractive surgeons have chosen to utilize them to treat myopia that is unresponsive to excimer laser treatment. A posterior chamber phakic intraocular lens (IOL) created and produced by STAAR Surgical, the Visian Implantable Collamer Lens (ICL), was FDA approved in 2005 and has been demonstrated to be effective in the correction of myopia up to 18.00 D.

Attributes	Key Insights
Implantable Collamer Lens Market Base Year Value (2021)	US$ 212.9 Mn
Estimated Market Size (2022)	US$ 244.8 Mn
Projected Market Valuation (2032)	US$ 838.2 Mn
Value-based CAGR (2022-2032)	13.1%
Key Market Players	STAAR SURGICAL

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15174

The ICL was only offered in the U.S. in a spherical variant until 2018. As a result, high astigmatism and high myopia could not be treated simultaneously. In light of this, several surgeons in the refractive fiend adopted a sequential operation strategy that employs the use of an excimer-laser enhancement after ICL implantation. This sequence has been referred to as “Bioptics”.

The use of ICL in refractive surgery is increasing. ICLs are often regarded as an alternative to laser-based corneal procedures such as LASIK and photorefractive keratectomy (PRK). The implantable collamer lens is a specific type of posterior chamber phakic intraocular lens (pIOL). High levels of refractive error or situations where corneal refractive surgery is not recommended call for the adoption of pIOL. Quicker healing and reversibility are the additional benefits of this procedure over corneal refractive surgery.

High incidence of cataracts and other vision impairments among elderly and diabetic individuals is underpinning the need for implantable collamer lens. In addition to this, rising healthcare costs, and government-backed investments for the construction of healthcare infrastructure are some of the key factors propelling the market.

“Growing prevalence of refractive disorders, and the emergence of alternatives to laser techniques for refractive correction are underpinning the demand for implantable collamer lens,” says and FMI analyst.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15174

Key Takeaways:

By indication, sales in the myopia segment are slated to increase at a 12.6% CAGR through 2032.
In terms of end user, demand in the hospitals segment will grow at a 7% CAGR during the forecast period.
China accounted for 6% of the total market share in 2021 and the trend is expected to continue over the assessment period.
The U.S. will continue dominating the North America implantable collamer lens market through 2032.
Japan will emerge as a lucrative pocket in the East Asia implantable collamer lens market.

Competition Landscape

The global implantable collamer lens market includes only one manufacturer known as STAR SURGICAL. Incorporated in 1982 for the purpose of developing, producing, and marketing implantable lenses, the company is the first to receive the U.S. FDA approval for implantable collamer lens. Some recent developments include:

In April 2021, STAAR submitted clinical data to the FDA to support a marketing approval for their EVO family of myopia lenses. The submission remains under interactive review with the FDA.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the implantable collamer lens market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the indication (myopia, hyperopia, and astigmatism), and end user (hospitals, ophthalmic clinics, ambulatory surgical centers, and eye research institutes), across seven key regions.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15174

Key Market Segments Covered in Implantable Collamer Lens Industry Research

By Indication:

Myopia
Hyperopia
Astigmatism

By End User:

Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Eye Research Institutes

About FMI: